MDMA-Assisted Therapy for Bulimia Nervosa
Part of Mental health clinical trials.
This study tests whether MDMA (a drug that enhances emotional processing) combined with therapy can help people with bulimia nervosa who haven't improved with previous eating disorder treatment. Researchers will measure whether this approach reduces binge eating and purging behaviors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with bulimia nervosa and continue to struggle with it despite at least one prior eating disorder treatment program
- You can live within about 2 hours of the study site and attend multiple in-person sessions
- You have a primary care doctor willing to communicate with the study team about your health
- You can identify a trusted support person (family member, friend, or partner) who can be contacted if needed
- You are in generally good physical and mental health—no severe liver or kidney problems, uncontrolled diabetes, untreated thyroid issues, or current serious suicide risk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the underlying brain and behavior mechanisms of anorexia nervosa or bulimia nervosa. It may help researchers understand what drives these conditions and what could be targeted in future treatments.
This study looks at how the brain and behavior respond to “expected rewards” in people with bulimia nervosa, compared with healthy volunteers. It may help researchers understand why symptoms continue and how future treatments could target those maintenance processes.
This trial tests if a single dose of MDMA, given under supervision, can help people with borderline personality disorder (BPD). You will stay overnight after the session and be followed up for two weeks.
This trial tests if MDMA-assisted therapy can help mental healthcare providers. It involves taking MDMA in a therapeutic setting while being recorded, and you must be trained in this type of therapy.
This trial tests different doses of MDMA (a drug sometimes called 'ecstasy') combined with therapy to see which dose works best for treating PTSD in veterans. The goal is to find a safer, more effective dose to help reduce PTSD symptoms.
This trial tests whether MDMA plus cognitive behavioral therapy (CBT) can reduce OCD symptoms in adults who have tried standard OCD treatments before. You may be asked to pause certain medicines and follow specific diet/medication rules around the study session.
Hear when a new Bulimia Nervosa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.